C
C. de Chaisemartin
Publications - 7
Citations - 221
C. de Chaisemartin is an academic researcher. The author has contributed to research in topics: FOLFOX & Hyperthermic intraperitoneal chemotherapy. The author has an hindex of 5, co-authored 7 publications receiving 157 citations.
Papers
More filters
Journal ArticleDOI
Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study
Vahan Kepenekian,Dominique Elias,Guillaume Passot,Eliane Mery,Diane Goéré,D. Delroeux,François Quenet,G. Ferron,Denis Pezet,Jean-Marc Guilloit,Pierre Meeus,Marc Pocard,J.M. Bereder,Karine Abboud,Catherine Arvieux,Cécile Brigand,Frédéric Marchal,J-M Classe,Gérard Lorimier,C. de Chaisemartin,Frédéric Guyon,Pascale Mariani,Pablo Ortega-Deballon,S. Isaac,C. Maurice,F. N. Gilly,Olivier Glehen,Gerlinde Averous,Frédéric Bibeau,D. Bouzard,A. Chevallier,S. Croce,Peggy Dartigues,S. Durand-Fontanier,L. Gouthi,Bruno Heyd,R. Kaci,R. Kianmanesh,M. H. Laverrière,Eric Leblanc,B. Lelong,A. Leroux,V. Loi,Christophe Mariette,S. Msika,P. Peyrat,Nicolas Pirro,J. Paineau,F. Poizat,Jack Porcheron,P. Rat,J.-M. Regimbeau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,V. Verriele,Philippe Zerbib,Franck Zinzindohoué +57 more
TL;DR: In this paper, the authors evaluated the impact of perioperative systemic chemotherapy strategies on survival and postoperative outcomes in patients with DMPM treated with curative intent with CRS-HIPEC, using a multi-institutional database: the French RENAPE network.
Journal ArticleDOI
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
Mehdi Karoui,Anne Rullier,Guillaume Piessen,Jean-Louis Legoux,Emilie Barbier,C. de Chaisemartin,Cedric Lecaille,O. Bouche,Hanifa Ammarguellat,Francesco Brunetti,Michel Prudhomme,Jean-Marc Regimbeau,Olivier Glehen,Astrid Lièvre,G. Portier,Johannes Hartwig,Gael Goujon,Benoit Romain,Côme Lepage,Julien Taieb,for Prodige investigators +20 more
TL;DR: Perioperative FOLFOX for locally advanced resectable CC is feasible with an acceptable tolerability but is not associated with an increased major pathological response rate as expected, however, perioperativeFOLFOX induces pathological regression and downstaging.
Journal ArticleDOI
A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application
Laurent Villeneuve,A. Thivolet,Naoual Bakrin,Faheez Mohamed,S. Isaac,Pierre-Jean Valette,Olivier Glehen,P. Rousset,Julio Abba,Karine Abboud,Catherine Arvieux,G. Balague,V. Barrau,Houda Ben Rejeb,J.M. Bereder,Frédéric Bibeau,D. Bouzard,Cécile Brigand,S. Carrere,M. Carretier,C. de Chaisemartin,M. Chassang,A. Chevallier,Thomas Courvoisier,Peggy Dartigues,D. Delroeux,G. Desolneux,A. Dohan,Clarisse Dromain,Frédéric Dumont,S. Durand-Fontanier,Dominique Elias,Clarisse Eveno,S. Evrard,O. Fay,G. Ferron,D. Geffroy,François-Noël Gilly,Julien Fontaine,Nicolas Goasguen,L. Ghouti,Diane Goéré,Jean-Marc Guilloit,Frédéric Guyon,Bruno Heyd,R. Kaci,Mehdi Karoui,R. Kianmanesh,C. Labbé,J. Lacroix,G. Lang-Averous,M. H. Laverrière,Jérémie H. Lefevre,B. Lelong,A. Leroux,Rea Lo Dico,V. Loi,Gérard Lorimier,Frédéric Marchal,A. Mariani,Pascale Mariani,Christophe Mariette,Pierre Meeus,E. Mery,M. Messager,S. Msika,Cédric Nadeau,Pablo Ortega-Deballon,Guillaume Passot,C. Petorin,P. Peyrat,Denis Pezet,Guillaume Piessen,Nicolas Pirro,Marc Pocard,F. Poizat,Jack Porcheron,G. Pourcher,François Quenet,P. Rat,Jean-Marc Regimbeau,P. Rousselot,Charles Sabbagh,Magali Svrcek,R. Tetreau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,Delphine Vaudoyer,S. Velasco,V. Verriele-Beurrier,Romuald Wernert,Franck Zinzindohoué +92 more
TL;DR: This application offers computer-assistance to produce simple, quick but precise and standardized pre, intra and postoperative reports of the extent of peritoneal metastases and may help specialized and non-specialized institutions in their current practice but also facilitate research and multicentre studies on peritoneAL surface malignancies.
Journal ArticleDOI
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.
G. Ferron,L. Simon,Frédéric Guyon,Olivier Glehen,Diane Goéré,Dominique Elias,Marc Pocard,Laurence Gladieff,J.M. Bereder,Cécile Brigand,J-M Classe,Jean-Marc Guilloit,François Quenet,Karine Abboud,Catherine Arvieux,Frédéric Bibeau,C. de Chaisemartin,D. Delroeux,S. Durand-Fontanier,Nicolas Goasguen,L. Gouthi,Bruno Heyd,R. Kianmanesh,Eric Leblanc,Valeria Loi,Gérard Lorimier,Frédéric Marchal,Pascale Mariani,Christophe Mariette,Pierre Meeus,S. Msika,Pablo Ortega-Deballon,J. Paineau,Denis Pezet,Guillaume Piessen,Nicolas Pirro,Christophe Pomel,Jack Porcheron,G. Pourcher,P. Rat,Jean-Marc Regimbeau,Charles Sabbagh,Emilie Thibaudeau,J.J. Torrent,David Tougeron,Jean-Jacques Tuech,Franck Zinzindohoué,P. Lundberg,F. Herin,Laurent Villeneuve +49 more
TL;DR: Protocols regarding cytoreductive surgery/HIPEC and the associated professional risks in France lack standardization and should be established.
Journal ArticleDOI
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
S. Valmary-Degano,Prudence Colpart,Laurent Villeneuve,F. Monnien,L. M'Hamdi,G. Lang Averous,M. Capovilla,Frédéric Bibeau,M. H. Laverrière,V. Verriele-Beurrier,H. Ben Rejeb,Peggy Dartigues,J. Hommell-Fontaine,François-Noël Gilly,S. Isaac,E. Mery,Julio Abba,Karine Abboud,Mohammad Alyami,Catherine Arvieux,Naoual Bakrin,G. Balague,V. Barrau,J.M. Bereder,I. Berton-Rigaud,I. Bonnefoy,D. Bouzard,I. Bricault,Cécile Brigand,S. Carrere,C. de Chaisemartin,M. Chassang,A. Chevallier,Thomas Courvoisier,A. Dohan,Clarisse Dromain,Julien Dubreuil,Frédéric Dumont,Clarisse Eveno,M. Faruch-Bilfeld,G. Ferron,Laure Fournier,Johan Gagnière,D. Geffroy,L. Ghouti,Laurence Gladieff,Olivier Glehen,Diane Goéré,A. Guibal,Jean-Marc Guilloit,Frédéric Guyon,Bruno Heyd,Christine Hoeffel,C. Hordonneau,P. Jourdan-Enfer,R. Kaci,R. Kianmanesh,C. Labbé-Devilliers,J. Lacroix,B. Lelong,A. Leroux-Broussier,Yoann Lherm,R. Lo Dico,Gérard Lorimier,Caroline Malhaire,Frédéric Marchal,Pascale Mariani,E. Mathiotte,Pierre Meeus,S. Msika,Cédric Nadeau,Pablo Ortega-Deballon,Guillaume Passot,O. Pellet,P. Peyrat,Denis Pezet,Nicolas Pirro,Marc Pocard,F. Poizat,Jack Porcheron,A. Poulet,François Quenet,P. Rat,P. Rousselot,H. Senellart,M. Serrano,Vincent Servois,O. Sgabura,Andrea Skanjeti,Magali Svrcek,R. Tetreau,Emilie Thibaudeau,Y. Touchefeu,Jean-Jacques Tuech,Delphine Vaudoyer,S. Velasco,Romuald Wernert,Franck Zinzindohoué +97 more
TL;DR: PD-L1 expression by immune cells evaluated with E1L3N was an independent prognostic factor in EPMM and Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy predicted better prognosis than other treatments.